Archives

New Key Developments

1. CDC is not reporting any major issues or red flags associated with the current clinical trials for the Novel Influenza A (H1N1) Vaccine.
   1. The National Institute of Allergy and Infectious Disease (NIAID) announced the initiation of Novel Influenza A (H1N1) clinical trials in pregnant women.
2. Public Health monitoring of the Novel Influenza A (H1N1) Virus has not identified any major mutation or shift in the virus from the virus that was circulating in the city of Milwaukee and the United States in the spring of 2009.

Novel Influenza A (H1N1) Surveillance

1. MHD’s local surveillance has identified an increase over the last several days for fever/flu visits to local emergency departments by individuals 18 – 39 years of age.
2. The CDC is reporting that 97% of all subtyped influenza A viruses being reported to the CDC were Novel Influenza A (H1N1) during the week of August 23rd – 29th.

CDC Health Advisory Antiviral Treatments for H1N1

1. November 18, 2009
   
   

City of Milwaukee Health Department (MHD) Activities

Situational Reports (PDF):

1. January 21, 2010
2. January 7, 2010
3. December 23, 2009

MHD is currently planning to initiate 3 vaccination sites within the city to vaccinate individuals who are listed within the five key target groups when Novel Influenza A (H1N1) vaccine becomes available, which is expected to be in mid-October.